HIGHLIGHTS
- What: The aim of this phase 3 trial was to demonstrate the noninferiority of 99mTc-Technegas compared with the standard 133Xe for lung ventilation scintigraphy. Lung perfusion scintigraphy was also performed using 99mTc-macroaggregated albumin, but those results were not included for the purposes of the current study. Despite these limitations, this study provides conclusive data on the comparability of quantification of relative lung ventilation with 99mTc-Technegas and 133 Xe.
- Who: from the Comparability of Quantifying Relative Lung Ventilation with Inhaled, mTc-Technegas and Xe in Patients Undergoing Evaluation for Lung Transplantation Ashwin Singh . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.